Correlation Between Merck and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Merck and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Pharvaris BV, you can compare the effects of market volatilities on Merck and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Pharvaris.
Diversification Opportunities for Merck and Pharvaris
Excellent diversification
The 3 months correlation between Merck and Pharvaris is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Merck i.e., Merck and Pharvaris go up and down completely randomly.
Pair Corralation between Merck and Pharvaris
Considering the 90-day investment horizon Merck Company is expected to under-perform the Pharvaris. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 3.64 times less risky than Pharvaris. The stock trades about -0.17 of its potential returns per unit of risk. The Pharvaris BV is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 2,171 in Pharvaris BV on August 26, 2024 and sell it today you would earn a total of 58.00 from holding Pharvaris BV or generate 2.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Pharvaris BV
Performance |
| Timeline |
| Merck Company |
| Pharvaris BV |
Merck and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Pharvaris
The main advantage of trading using opposite Merck and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Merck vs. Capricor Therapeutics | Merck vs. Soleno Therapeutics | Merck vs. Bio Path Holdings | Merck vs. Moleculin Biotech |
| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |